Pentagen Tech. Int'l Ltd. v. Caci Int'l Inc., 540 U.S. 940 (2003). · Go Syfert
Search
Pentagen Tech. Int'l Ltd. v. Caci Int'l Inc., 540 U.S. 940 (2003). Cases Citing This Book View Copy Cite
37 citation events (37 in the last 25 years) across 9 distinct courts.
Strongest positive: Miller v. Johnson & Johnson, Janssen Pharmaceuticals, Inc. (flmd, 2015-01-14)
Treatment trajectory · 2004 → 2026 · click a year to view as-of
2004 2015 2026
Top citers, strongest first. 2 distinct citers. How cited ↗
cited Cited as authority (rule) Miller v. Johnson & Johnson, Janssen Pharmaceuticals, Inc.
M.D. Fla. · 2015 · confidence medium
Id. at 391-92 (citations and footnote omitted) (emphasis in original).
discussed Cited "see, e.g." Prelich v. Medical Resources, Inc.
D. Maryland · 2011 · signal: see also · confidence low
In considering a motion to dismiss, the court must “accept the well-pled allegations of the complaint as true,” and “construe facts and reasonable inferences derived therefrom in the light most favorable to the plaintiff.” Ibarra v. United States, 120 F.3d 472, 474 (4th Cir.1997); see also Bass v. E.I. du Pont de Nemours & Co., 324 F.3d 761, 764 (4th Cir.), cert. denied, 540 U.S. 940 , 124 S.Ct. 301 , 157 L.Ed.2d 253 (2003).
Retrieving the full opinion text from the archive…
Pentagen Technologies International Ltd. Et Al.
v.
CACI International Inc. Et Al.
03-102.
Supreme Court of the United States.
Oct 6, 2003.
540 U.S. 940
Breyer.
Published

C. A. 2d Cir. Certiorari denied.

Justice Breyer took no part in the consideration or decision of this petition.